UCP1 and breast cancer: To further demonstrate the therapeutic potential of AMT, we treated adipocytes obtained from dissected human breast tissues with UCP1-CRISPRa AAV9 and tested their ability to suppress tumor progression by co-culturing them with breast cancer organoids generated from dissected breast tumors or grown from metastatic pleural effusions (Fig. 5a).